Tenet Healthcare diskutieren
Tenet Healthcare
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /
139,00 €
2,22 %
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $84.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Raymond James from $85.00 to $95.00. They now have a "strong-buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $89.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Cantor Fitzgerald from $76.00 to $94.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Wells Fargo & Company from $83.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Royal Bank of Canada from $87.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Mizuho from $94.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Raymond James from $95.00 to $90.00. They now have a "strong-buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at UBS Group AG from $104.00 to $94.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $98.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $95.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at JPMorgan Chase & Co. from $91.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $92.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Cantor Fitzgerald from $94.00 to $104.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Mizuho from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $109.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Truist Financial Co. from $92.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $98.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Lululemon Athletica Inc. diskutieren